• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

o,p'DDD疗法对垂体依赖性肾上腺皮质功能亢进犬内源性促肾上腺皮质激素浓度的影响。

Effect of o,p'DDD therapy on endogenous ACTH concentrations in dogs with hypophysis-dependent hyperadrenocorticism.

作者信息

Nelson R W, Feldman E C, Shinsako J

出版信息

Am J Vet Res. 1985 Jul;46(7):1534-7.

PMID:2992329
Abstract

The effect of o,p'DDD therapy on the endogenous plasma ACTH concentration was evaluated in 15 dogs with hypophysis-dependent hyperadrenocorticism. Adequate control of hyperadrenocorticism with o,p'DDD was based on the reduction of water consumption to within the normal range, disappearance of clinical signs of lethargy, weakness, alopecia, thin skin, or pendulous abdomen, and an increase in blood cortisol below the normal range after exogenous ACTH administration. Endogenous ACTH concentrations were determined for each dog after the disease was controlled and while they were given o,p'DDD on a maintenance schedule. Endogenous ACTH concentrations increased in 14 of 15 dogs after o,p'DDD therapy, indicating a lack of suppressive effects of o,p'DDD on hypophysis ACTH secreting cells.

摘要

在15只垂体依赖性肾上腺皮质功能亢进的犬中评估了邻对滴滴滴(o,p'DDD)疗法对血浆内源性促肾上腺皮质激素(ACTH)浓度的影响。用邻对滴滴滴充分控制肾上腺皮质功能亢进的标准是:饮水量降至正常范围、嗜睡、虚弱、脱毛、皮肤变薄或腹部下垂等临床症状消失,以及在外源性促肾上腺皮质激素给药后血皮质醇水平降至正常范围以下。在疾病得到控制且犬只按维持方案给予邻对滴滴滴时,测定每只犬的内源性促肾上腺皮质激素浓度。15只犬中有14只在接受邻对滴滴滴治疗后内源性促肾上腺皮质激素浓度升高,表明邻对滴滴滴对垂体促肾上腺皮质激素分泌细胞缺乏抑制作用。

相似文献

1
Effect of o,p'DDD therapy on endogenous ACTH concentrations in dogs with hypophysis-dependent hyperadrenocorticism.o,p'DDD疗法对垂体依赖性肾上腺皮质功能亢进犬内源性促肾上腺皮质激素浓度的影响。
Am J Vet Res. 1985 Jul;46(7):1534-7.
2
Evaluation of a combined dexamethasone suppression/ACTH stimulation test in dogs with hyperadrenocorticism.对患有肾上腺皮质功能亢进症的犬进行地塞米松抑制/促肾上腺皮质激素刺激联合试验的评估。
J Am Vet Med Assoc. 1985 Jul 1;187(1):49-53.
3
Use of urine cortisol:creatinine ratio versus adrenocorticotropic hormone stimulation testing for monitoring mitotane treatment of pituitary-dependent hyperadrenocorticism in dogs.尿皮质醇:肌酐比值与促肾上腺皮质激素刺激试验在监测犬垂体依赖性肾上腺皮质功能亢进米托坦治疗中的应用比较
J Am Vet Med Assoc. 1997 Oct 15;211(8):1002-4.
4
Evaluation of a six-hour combined dexamethasone suppression/ACTH stimulation test in dogs with hyperadrenocorticism.对患有肾上腺皮质功能亢进的犬进行六小时联合地塞米松抑制/促肾上腺皮质激素刺激试验的评估。
J Am Vet Med Assoc. 1986 Dec 15;189(12):1562-6.
5
Use of the urine cortisol-to-creatinine ratio for monitoring dogs with pituitary-dependent hyperadrenocorticism during induction treatment with mitotane (o,p'-DDD).在使用米托坦(邻,对'-滴滴滴)进行诱导治疗期间,利用尿皮质醇与肌酐比值监测垂体依赖性肾上腺皮质功能亢进症犬。
Am J Vet Res. 1998 Mar;59(3):258-61.
6
A case of adrenal gland dependent hyperadrenocorticism with mitotane therapy in a Yorkshire terrier dog.一只约克夏梗犬肾上腺依赖性肾上腺皮质功能亢进接受米托坦治疗的病例。
J Vet Sci. 2005 Dec;6(4):363-6.
7
Problems associated with medical therapy of canine hyperadrenocorticism.犬肾上腺皮质功能亢进症药物治疗相关问题。
Probl Vet Med. 1990 Dec;2(4):551-6.
8
Comparison of mitotane treatment for adrenal tumor versus pituitary-dependent hyperadrenocorticism in dogs.米托坦治疗犬肾上腺肿瘤与垂体依赖性肾上腺皮质功能亢进的比较。
J Am Vet Med Assoc. 1992 Jun 1;200(11):1642-7.
9
Suppression of growth hormone secretion in spontaneous canine hyperadrenocorticism and its reversal after treatment.
Am J Vet Res. 1981 Nov;42(11):1881-3.
10
Evaluation of a low-dose synthetic adrenocorticotropic hormone stimulation test in clinically normal dogs and dogs with naturally developing hyperadrenocorticism.低剂量合成促肾上腺皮质激素刺激试验在临床正常犬和自然发生肾上腺皮质功能亢进犬中的评估。
J Am Vet Med Assoc. 1999 May 15;214(10):1497-501.

引用本文的文献

1
Effects of Carbenoxolone on the Canine Pituitary-Adrenal Axis.甘珀酸对犬垂体-肾上腺轴的影响。
PLoS One. 2015 Aug 11;10(8):e0135516. doi: 10.1371/journal.pone.0135516. eCollection 2015.